Wendy Beck, Earl Fry, Lawrence Hershfield, Jayne Hrdlicka, Peter Ingram, Michael McNamara, Crystal Rose, Craig Vosburg and Richard Zwern, each of whom was a director of Hawaiian as of immediately prior to the Effective Time, ceased to be a director of Hawaiian and a member of any committee of Hawaiian’s Board of Directors.
Departed
Lawrence Hershfield
Director
HAWAIIAN HOLDINGS INC
Effective
2024-09-18
Filed
September 18, 2024, 7:59 PM ET
Wendy Beck, Earl Fry, Lawrence Hershfield, Jayne Hrdlicka, Peter Ingram, Michael McNamara, Crystal Rose, Craig Vosburg and Richard Zwern, each of whom was a director of Hawaiian as of immediately prior to the Effective Time, ceased to be a director of Hawaiian and a member of any committee of Hawaiian’s Board of Directors.
Departed
Crystal Rose
Director
HAWAIIAN HOLDINGS INC
Effective
2024-09-18
Filed
September 18, 2024, 7:59 PM ET
Wendy Beck, Earl Fry, Lawrence Hershfield, Jayne Hrdlicka, Peter Ingram, Michael McNamara, Crystal Rose, Craig Vosburg and Richard Zwern, each of whom was a director of Hawaiian as of immediately prior to the Effective Time, ceased to be a director of Hawaiian and a member of any committee of Hawaiian’s Board of Directors.
Departed
Wendy Beck
Director
HAWAIIAN HOLDINGS INC
Effective
2024-09-18
Filed
September 18, 2024, 7:59 PM ET
Wendy Beck, Earl Fry, Lawrence Hershfield, Jayne Hrdlicka, Peter Ingram, Michael McNamara, Crystal Rose, Craig Vosburg and Richard Zwern, each of whom was a director of Hawaiian as of immediately prior to the Effective Time, ceased to be a director of Hawaiian and a member of any committee of Hawaiian’s Board of Directors.
Appointed
Joseph Sprague
Director
HAWAIIAN HOLDINGS INC
Effective
2024-09-18
Filed
September 18, 2024, 7:59 PM ET
Joseph Sprague, Diana Rakow, Andrea Schneider, and Eric Yeaman were appointed as members of Hawaiian’s Board of Directors to serve until the earlier of their death, resignation or removal or until their respective successors are duly elected and qualified.
Departed
Michael McNamara
Director
HAWAIIAN HOLDINGS INC
Effective
2024-09-18
Filed
September 18, 2024, 7:59 PM ET
Wendy Beck, Earl Fry, Lawrence Hershfield, Jayne Hrdlicka, Peter Ingram, Michael McNamara, Crystal Rose, Craig Vosburg and Richard Zwern, each of whom was a director of Hawaiian as of immediately prior to the Effective Time, ceased to be a director of Hawaiian and a member of any committee of Hawaiian’s Board of Directors.
Appointed
Eric Yeaman
Director
HAWAIIAN HOLDINGS INC
Effective
2024-09-18
Filed
September 18, 2024, 7:59 PM ET
Joseph Sprague, Diana Rakow, Andrea Schneider, and Eric Yeaman were appointed as members of Hawaiian’s Board of Directors to serve until the earlier of their death, resignation or removal or until their respective successors are duly elected and qualified.
Appointed
Diana Rakow
Director
HAWAIIAN HOLDINGS INC
Effective
2024-09-18
Filed
September 18, 2024, 7:59 PM ET
Joseph Sprague, Diana Rakow, Andrea Schneider, and Eric Yeaman were appointed as members of Hawaiian’s Board of Directors to serve until the earlier of their death, resignation or removal or until their respective successors are duly elected and qualified.
Appointed
Andrea Schneider
Director
HAWAIIAN HOLDINGS INC
Effective
2024-09-18
Filed
September 18, 2024, 7:59 PM ET
Joseph Sprague, Diana Rakow, Andrea Schneider, and Eric Yeaman were appointed as members of Hawaiian’s Board of Directors to serve until the earlier of their death, resignation or removal or until their respective successors are duly elected and qualified.
Departed
John E. Bailey, Jr.
director
G1 Therapeutics, Inc.
Filed
September 18, 2024, 7:59 PM ET
each of John E. Bailey, Jr., Cynthia L. Flowers, Jacks Lee, Glenn P. Muir, Garry A. Nicholson, Alicia Secor and Norman E. Sharpless, M.D. resigned as directors of the Company
Departed
Jacks Lee
director
G1 Therapeutics, Inc.
Filed
September 18, 2024, 7:59 PM ET
each of John E. Bailey, Jr., Cynthia L. Flowers, Jacks Lee, Glenn P. Muir, Garry A. Nicholson, Alicia Secor and Norman E. Sharpless, M.D. resigned as directors of the Company
Departed
Cynthia L. Flowers
director
G1 Therapeutics, Inc.
Filed
September 18, 2024, 7:59 PM ET
each of John E. Bailey, Jr., Cynthia L. Flowers, Jacks Lee, Glenn P. Muir, Garry A. Nicholson, Alicia Secor and Norman E. Sharpless, M.D. resigned as directors of the Company
Appointed
Josh Franklin
director
G1 Therapeutics, Inc.
Filed
September 18, 2024, 7:59 PM ET
the director of Purchaser, Josh Franklin, became the director of the Company
Departed
Alicia Secor
director
G1 Therapeutics, Inc.
Filed
September 18, 2024, 7:59 PM ET
each of John E. Bailey, Jr., Cynthia L. Flowers, Jacks Lee, Glenn P. Muir, Garry A. Nicholson, Alicia Secor and Norman E. Sharpless, M.D. resigned as directors of the Company
Departed
Norman E. Sharpless, M.D.
director
G1 Therapeutics, Inc.
Filed
September 18, 2024, 7:59 PM ET
each of John E. Bailey, Jr., Cynthia L. Flowers, Jacks Lee, Glenn P. Muir, Garry A. Nicholson, Alicia Secor and Norman E. Sharpless, M.D. resigned as directors of the Company
Departed
Garry A. Nicholson
director
G1 Therapeutics, Inc.
Filed
September 18, 2024, 7:59 PM ET
each of John E. Bailey, Jr., Cynthia L. Flowers, Jacks Lee, Glenn P. Muir, Garry A. Nicholson, Alicia Secor and Norman E. Sharpless, M.D. resigned as directors of the Company
Departed
Glenn P. Muir
director
G1 Therapeutics, Inc.
Filed
September 18, 2024, 7:59 PM ET
each of John E. Bailey, Jr., Cynthia L. Flowers, Jacks Lee, Glenn P. Muir, Garry A. Nicholson, Alicia Secor and Norman E. Sharpless, M.D. resigned as directors of the Company
On September 17, 2024, Sarah Bond and Dr. Paul LeBlanc, each members of the Board of Directors (the “Board”) of Chegg, Inc. (the “Company”), notified the Company of their respective decisions to resign from the Board, effective September 18, 2024.
On September 17, 2024, Sarah Bond and Dr. Paul LeBlanc, each members of the Board of Directors (the “Board”) of Chegg, Inc. (the “Company”), notified the Company of their respective decisions to resign from the Board, effective September 18, 2024.
On September 18, 2024, upon the recommendation of the Nominating and Governance Committee, the Board of Directors (the “Board”) of MetroCity Bankshares, Inc. (the “Company”) appointed Mr. John Paek to serve as a member of the Boards of the Company and Metro City Bank, the wholly owned subsidiary of the Company (the “Bank”), effective immediately.
On September 16, 2024, the Trustees of North European Oil Royalty Trust (the "Trust") appointed Richard P. Howard and Andrew S. Borodach as Trustees of the Trust effective October 1, 2024.
On September 16, 2024, the Trustees of North European Oil Royalty Trust (the "Trust") appointed Richard P. Howard and Andrew S. Borodach as Trustees of the Trust effective October 1, 2024.
On September 16, 2024, the Board of Directors (the “Board”) of Southern California Gas Company, a subsidiary of Sempra (“SoCalGas”), appointed Peter R. Wall, the Senior Vice President, Controller and Chief Accounting Officer of Sempra, as a director of SoCalGas effective the same day.
On September 16, 2024, James J. Marino, a member of the Board of Directors (the “Board”) of Traws Pharma, Inc. (the “Company”), resigned as a director.
the Board appointed Luba Greenwood to the Board to fill the vacancy created by Mr. Marino’s resignation with a term expiring at the Company’s 2024 annual meeting of stockholders.
On September 11, 2024, Linda B. Abraham, Terrance R. Ahern, Jane E. DeFlorio, Victor B. MacFarlane, Alexander Otto and Barry A. Sholem (collectively, the “ Resigning Directors ”) informed the Company of their intentions to resign from the Board, effective on the Antecedent Date.
On September 11, 2024, Linda B. Abraham, Terrance R. Ahern, Jane E. DeFlorio, Victor B. MacFarlane, Alexander Otto and Barry A. Sholem (collectively, the “ Resigning Directors ”) informed the Company of their intentions to resign from the Board, effective on the Antecedent Date.
On September 11, 2024, Linda B. Abraham, Terrance R. Ahern, Jane E. DeFlorio, Victor B. MacFarlane, Alexander Otto and Barry A. Sholem (collectively, the “ Resigning Directors ”) informed the Company of their intentions to resign from the Board, effective on the Antecedent Date.
the Board appointed the following directors to fill the vacancies on the Board caused by the resignations of the Resigning Directors (taking into account the reduction in Board size referred to above), in each case, effective on the Antecedent Date: Gary N. Boston, John M. Cattonar and Cynthia Foster Curry (collectively, the “ New Directors ”).
On September 11, 2024, Linda B. Abraham, Terrance R. Ahern, Jane E. DeFlorio, Victor B. MacFarlane, Alexander Otto and Barry A. Sholem (collectively, the “ Resigning Directors ”) informed the Company of their intentions to resign from the Board, effective on the Antecedent Date.
the Board appointed the following directors to fill the vacancies on the Board caused by the resignations of the Resigning Directors (taking into account the reduction in Board size referred to above), in each case, effective on the Antecedent Date: Gary N. Boston, John M. Cattonar and Cynthia Foster Curry (collectively, the “ New Directors ”).
On September 11, 2024, Linda B. Abraham, Terrance R. Ahern, Jane E. DeFlorio, Victor B. MacFarlane, Alexander Otto and Barry A. Sholem (collectively, the “ Resigning Directors ”) informed the Company of their intentions to resign from the Board, effective on the Antecedent Date.
On September 11, 2024, Linda B. Abraham, Terrance R. Ahern, Jane E. DeFlorio, Victor B. MacFarlane, Alexander Otto and Barry A. Sholem (collectively, the “ Resigning Directors ”) informed the Company of their intentions to resign from the Board, effective on the Antecedent Date.
the Board appointed the following directors to fill the vacancies on the Board caused by the resignations of the Resigning Directors (taking into account the reduction in Board size referred to above), in each case, effective on the Antecedent Date: Gary N. Boston, John M. Cattonar and Cynthia Foster Curry (collectively, the “ New Directors ”).
On September 13, 2024, the Board of Directors (the “Board”) of Kura Oncology, Inc. (the “Company”), upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Michael J. Vasconcelles, M.D. as (i) a Class III director of the Company
On September 17, 2024, the Board of Directors (the “Board”) of Canadian Pacific Kansas City Limited (the “Corporation”) appointed Arturo Gutiérrez Hernández to the Board, effective as of November 1, 2024, to serve until the close of the Corporation’s next annual meeting of shareholders, unless Mr. Gutiérrez resigns or is otherwise removed earlier.
On July 8, 2024, Mr. John Seery retired from the Board of Directors
Departed
Ryan J. Faulkingham
regular trustee of the Trust
Compass Group Diversified Holdings LLC
Effective
2024-08-30
Filed
September 17, 2024, 7:59 PM ET
Mr. Faulkingham resigned from all officer and director positions he held with the Manager, the Company and the Trust and their respective affiliates (including any committee thereof).
On September 17, 2024, the Board of Directors (the “Board”) of Bright Horizons Family Solutions Inc. (the “Company”) appointed Jennifer Schulz as a member of the Board effective immediately.
Appointed
Giorgi Sambadze
director
KHEOBA CORP.
Effective
2024-09-17
Filed
September 17, 2024, 7:59 PM ET
on September 17, 2024, Mr. Giorgi Sambadze appointed as a director of the Company.
On September 17, 2024, Aneek S. Mamik resigned from the Board of Directors (the “Board”) of OneMain Holdings, Inc. (the “Company”), effective immediately.
elected Mr. Daniel Colao as a director of the Company and appointed him to serve on the Risk and Technology Committees of the Board, effective October 1, 2024.
Departed
David Heidecorn
director
BurgerFi International, Inc.
Effective
2024-09-16
Filed
September 17, 2024, 7:59 PM ET
On September 16, 2024, David Heidecorn resigned from the board of directors of the Company, effective immediately.
Departed
Vanila M. Singh
member of the Board of Directors
Virpax Pharmaceuticals, Inc.
Effective
2024-09-16
Filed
September 17, 2024, 7:59 PM ET
On September 16, 2024, Vanila M. Singh, MD, a member of the Board of Directors (the “Board”) of Virpax Pharmaceuticals, Inc. (the “Company”), notified the Company of her intention to resign from the Board, effective immediately.
Departed
Kush Parmar
Member of the Board and Chair of the Nominating and Corporate Governance Committee
On September 16, 2024, Dr. Kush Parmar informed the Board of Directors (the Board) of Rallybio Corporation (Rallybio) that he intends to resign as a member of the Board and as Chair of the Nominating and Corporate Governance Committee of the Board effective October 31, 2024.
On September 16 , 2024, the Board of Directors (the “Board”) of La-Z-Boy Incorporated (the “Company”) elected Matthew Baer to the Board, effective January 1, 2025.
On September 13, 2024, the Board of Directors (the “Board”) of Darling Ingredients Inc. (the “Company”) elected Randy L. Hill to the Board and appointed him as a member of the Board’s Audit Committee and Sustainability Committee, effective immediately.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.